Aspirin and coronary artery surgery: A systematic review and meta-analysis

British Journal of Anaesthesia

Volumn 115, Issue 3, 2015, Pages 376-385

  Hastings, S ^a   Myles, P ^a,b   McIlroy, D ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

aspirin; blood transfusion; coronary artery bypass; myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; APROTININ; PLACEBO; TRANEXAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; CARDIOVASCULAR MORTALITY; CHEST TUBE; CORONARY ARTERY SURGERY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART INFARCTION; HUMAN; MALE; META ANALYSIS; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; BLOOD TRANSFUSION; CHEMICALLY INDUCED; CORONARY BLOOD VESSEL; HEART SURGERY; MYOCARDIAL INFARCTION; OPERATIVE BLOOD LOSS; PREOPERATIVE CARE; PROCEDURES; STATISTICS AND NUMERICAL DATA; SURGERY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CORONARY VESSELS; HUMANS; MYOCARDIAL INFARCTION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE;

EID: 84942251246     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aev164     Document Type: Review

References (41)

1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002; 324: 71-86
2. Bell AD, Roussin A, Cartier R, et al. The use of antiplatelet therapy in the outpatient setting: Canadian cardiovascular society guidelines. Can J Cardiol 2011; 27(Suppl A): S1-59
3. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2011; 124: 2610-42
4. Goldman S, Copeland J, Moritz T, et al. Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs cooperative study group. Circulation 1991; 84: 520-6
5. Alghamdi AA, Moussa F, Fremes SE. Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis. J Card Surg 2007; 22: 247-56
6. Sun JCJ, Whitlock R, Cheng J, et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: A systematic review of randomized and observational studies. Eur Heart J 2008; 29: 1057-71
7. Jacob M, Smedira N, Blackstone E,Williams S, Cho L. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery. Circulation 2011; 123: 577-83
8. Torosian M, Michelson EL, Morganroth J, MacVaugh H. Aspirin-and coumadin-related bleeding after coronary artery bypass graft surgery. Ann Intern Med 1978; 89: 325-8
9. Gerrah R, Ehrlich S, Tshori S, Sahar G. Beneficial effect of aspirin on renal function in patients with renal insufficiency postcardiac surgery. J Cardiovasc Surg 2004; 45: 545-50
10. Michelson EL, Morganroth J, Torosian M, MacVaugh H III. Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 1978; 76: 694-7
11. Gerrah R, Elami A, Stamler A, Smirnov A, Stoeger Z. Preoperative aspirin administration improves oxygenation in patients under-going coronary artery bypass grafting. Chest 2005; 127: 1622-6
12. Myles PS. Stopping aspirin before coronary artery surgery: Between the devil and the deep blue sea. Circulation 2011; 123: 571-3
13. Mangano D. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347: 1309-17
14. Dacey LJ, Munoz JJ, Johnson ER, et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg 2000; 70: 1986-90
15. Bybee KA, Powell BD, Valeti U, et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 2005; 112: 1286-1292
16. Douketis JD, Berger PB, Dunn AS, et al. Perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (9th edition). Chest 2012; 141: e326S-50S
17. Ferraris VA, Saha SP, Oestreich JH, et al. 2012 update to the society of thoracic surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 2012; 94: 1761-81
18. Higgins JP, Altman DG, Gotzsche PC, et al. The cochrane collaboration's tool for assessing risk of bias in randomised trials. Br Med J 2011; 343: d5928
19. Fuller JK, Copeland JG. Does short-term pre-operative aspirin in coronary bypass patients increase post-operative bleeding? Vasc Endovascular Surg 1985; 19: 174-8
20. Karwande SV,Weksler BB, GayWA Jr, Subramanian VA. Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis. Ann Thorac Surg 1987; 43: 318-22
21. Ferraris VA, Ferraris SP, Lough FC, Berry WR. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg 1988; 45: 71-4
22. Sethi GK, Copeland JG, Goldman S, Moritz T, Zadina K, Henderson WG. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs cooperative study on antiplatelet therapy. J Am Coll Cardiol 1990; 15: 15-20
23. Hockings BE, Ireland MA, Gotch-Martin KF, Taylor RR. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency. Med J Aust 1993; 159: 376-8
24. Kallis P, Tooze JA, Talbot S, Cowans D, Bevan DH, Treasure T. Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss-a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg 1994; 8: 404-9
25. Klein M, Keith PR, Dauben HP, et al. Aprotinin counterbalances an increased risk of peri-operative hemorrhage in cabg patients pre-treated with aspirin. Eur J Cardiothorac Surg 1998; 14: 360-6
26. Morawski W, Sanak M, Cisowski M, et al. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism. J Thorac Cardiovasc Surg 2005; 130: 791-6
27. Ghaffarinejad MH, Fazelifar AF, Shirvani SM, et al. The effect of preoperative aspirin use on postoperative bleeding and perioperative myocardial infarction in patients undergoing coronary artery bypass surgery. Cardiol J 2007; 14: 453-7
28. Deja MA, Kargul T, Domaradzki W, et al. Effects of preoperative aspirin in coronary artery bypass grafting: A doubleblind, placebo-controlled, randomized trial. J Thorac Cardiovasc Surg 2012; 144: 204-9
29. Berg K, Langaas M, Ericsson M, et al. Acetylsalicylic acid treatment until surgery reduces oxidative stress and inflammation in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 2013; 43: 1154-63
30. Mirhosseini SJ, Forouzannia SK, Mostafavi Pour Manshadi SM, et al. Comparison of aspirin plus heparin with heparin alone on asymptomatic perioperative deep vein thrombosis in candidates for elective off-pump coronary artery bypass graft: A randomized clinical trial. Cardiol J 2013; 20: 139-43
31. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13
32. Mehta RH, Sheng S, O'Brien SM, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: Incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes 2009; 2: 583-90
33. Guyatt G, Oxman A, Vist G. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J 2008; 336: 924-6
34. Ranucci M, Bozzetti G, Ditta A, Cotza M, Carboni G, Ballotta A. Surgical reexploration after cardiac operations: Why a worse outcome? Ann Thorac Surg 2008; 86: 1557-62
35. Vivacqua A, Kock C, Yousuf A, et al. Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding or both? Ann Thorac Surg 2011; 91: 1780-90
36. Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014; 370: 1494-503
37. Hausenloy DJ, Boston-Griffiths E, Yellon DM. Cardioprotection during cardiac surgery. Cardiovasc Res 2012; 94: 253-65
38. D'Ancona G, Karamanoukian HL, Ricci M, Schmid S, Bergsland J, Salerno TA. Graft revision after transit time flow measurement in off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 2000; 17: 287-93
39. McIlroy DR, Myles PS, Phillips LE, Smith JA. Antifibrinolytics in cardiac surgical patients receiving aspirin: A systematic review and meta-analysis. Br J Anaesth 2009; 102: 168-78
40. Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest 1975; 56: 624-32
41. Roth GJ, Stanford N,Majerus PW. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA 1975; 72: 3073-6